EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan

Lauren A Wimer, Kiyomi R Kaneshiro, Jessica Ramirez, Neelanjan Bose, Martin Valdearcos, Muniesh Muthaiyan Shanmugam, Dominique O Farrera, Parminder Singh, Jennifer Beck, Durai Sellegounder, Lizbeth Enqriquez Najera, Simon Melov und 6 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Lauren A Wimer und 17 weiteren Autor:innen. Beteiligte Einrichtung: Buck Institute for Research on Aging, Novato, CA 94949, USA. Hauptthemen laut MEDLINE: Ghrelin, Insulin Resistance, Signal Transduction, Eating. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Larry L Hillblom Foundation, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GhrelinInsulin ResistanceSignal TransductionEatingLongevityAnimalsMiceMice, Inbred C57BLMalePiperidinesPolyunsaturated AlkamidesAMP-Activated Protein KinasesGlycation End Products, AdvancedReceptors, LeptinBenzodioxolesAlkaloidsHypothalamusPyruvaldehyde

Stichwörter der Autor:innen

CP: Metabolismagingappetitediabetesghrelinglycationhypothalamusleptinlifespanmethylglyoxalobesity

Substanzen

GhrelinPiperidinesPolyunsaturated AlkamidesAMP-Activated Protein KinasesGlycation End Products, AdvancedReceptors, LeptinBenzodioxolesAlkaloidspiperinePyruvaldehyde

Autor:innen und Institutionen

  • Buck Institute for Research on Aging, Novato, CA 94949, USA.
  • The Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • University of Arizona, Tucson, AZ, USA.
  • Surgical Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Buck Institute for Research on Aging, Novato, CA 94949, USA. Electronic address: pkapahi@buckinstitute.org.

Förderung

  • NIA NIH HHS
  • Larry L Hillblom Foundation
  • National Institute on Aging

Zitieren

APA

Wimer, L. A., Kaneshiro, K. R., Ramirez, J., Bose, N., Valdearcos, M., Shanmugam, M. M., Farrera, D. O., Singh, P., Beck, J., Sellegounder, D., Najera, L. E., Melov, S., Ellerby, L. M., Cho, S. J., Newman, J. C., Koliwad, S., Galligan, J. J., & Kapahi, P. (2025). Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116422

Vancouver

Wimer LA, Kaneshiro KR, Ramirez J, Bose N, Valdearcos M, Shanmugam MM, et al. Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116422

BibTeX
@article{Wimer2025,
  author = {Wimer, Lauren A and Kaneshiro, Kiyomi R and Ramirez, Jessica and Bose, Neelanjan and Valdearcos, Martin and Shanmugam, Muniesh Muthaiyan and Farrera, Dominique O and Singh, Parminder and Beck, Jennifer and Sellegounder, Durai and Najera, Lizbeth Enqriquez and Melov, Simon and Ellerby, Lisa M and Cho, Soo-Jin and Newman, John C and Koliwad, Suneil and Galligan, James J and Kapahi, Pankaj},
  title = {Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116422}
}
Kostenlos starten →